InMedica Group provides primary, specialist, dental, and hospital care. Credit: Mehiläinen.

Finnish social care and healthcare provider Mehiläinen has signed an agreement to acquire Lithuania based InMedica Group from INVL Baltic Sea Growth Fund, AB City and Litgaja.

Litgaja is controlled by InMedica founder and CEO Kęstutis Broniukaitis.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

This acquisition is contingent upon regulatory approval and is a strategic move for Mehiläinen.

InMedica Group, a medical network, provides specialist, primary, dental, hospital care, along with mental health services and diagnostics in Lithuania.

Catering to a wide patient demographic, it serves individuals, corporations, and public health insurance beneficiaries.

The group has 89 facilities, facilitating more than 2.7 million physician visits each year and serves as the primary healthcare provider for over 310,000 patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

InMedica board chairman Nerijus Drobavičus said: “After evaluating potential investors, we believe that Mehiläinen is the best possible next owner for the InMedica Group, as it has exceptional resources, capabilities, and the corporate culture to support InMedica Group’s continued growth and development.”

Mehiläinen and InMedica Group share similar service portfolios and business models.

Mehiläinen’s acquisition of InMedica Group is not expected to directly affect the personnel or patients of InMedica Group.

Operations will continue as normal, ensuring a smooth transition for all parties involved.

Mehiläinen Baltic business line director Andreas Taalas said: “The private healthcare market in Lithuania is growing rapidly, and InMedica Group is a high-quality market leader with an excellent reputation. I’m excited to work with Kęstutis and the management team. Together, we can continue the successful growth and further enhance the services provided.”

Jefferies, Deloitte, LEK Consulting, and Walless advised InMedica Group while Porta Finance, EY and Cobalt served as Mehiläinen’s advisors.